Metabolite profiling of dasatinib dosed to Wistar Han rats using automated dried blood spot collection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 67-68, Issue , 2012, Pages 92-97

  Shen, Zhongzhou ^a   Kang, Ping ^a   Rahavendran, Sadayappan V ^a  

^a PFIZER INC   (United States)

Author keywords

Automated DBS collection; Dasatinib; Metabolite profiling

Indexed keywords

ACETONITRILE; DASATINIB; METHANOL;

ARTICLE; AUTOMATION; BLOOD SAMPLING; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; DRUG BLOOD LEVEL; DRUG SCREENING; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; AUTOMATION; BLOOD; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RATS; RATS, WISTAR; THIAZOLES;

EID: 84862133090     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.04.013     Document Type: Article

References (20)

1. Li W., Tse F.L.S. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 2010, 24:49-65.
2. Howard H. Developing trends in bioanalysis. Bioanalysis 2009, 1:1359-1364.
3. Mather J., Rainville P.D., Spooner Sn., Evans C.A., Smith N.W., Plumb R.S. Rapid analysis of dried blood spot samples with sub-2μm LC-MS/MS. Bioanalysis 2011, 3:411-420.
4. Parker S.P., Cubit A.W.S. The use of the dried blood spot samples in empidemiological studies. J. Clin. Pathol. 1999, 52:633-639.
5. Wilcken B., Wiley V. Newborn screening. Pathology 2008, 40:104-105.
6. Rinaldo P., Tortorelli S., Matern S. Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr. Opin. Pediatr. 2004, 16:427-433.
7. Edelbroek P.M., van der Heijden J., Stolk L.M.L. Dried blood spot methods in therapeutic durg monitoring:methods, assays and pitfalls. Ther. Drug Monit. 2009, 31:327-336.
8. Beaudette P., Bateman K.P. Discovery stage pharmacokinetics using dried blood spots. J. Chromatogr. B 2004, 809:151-158.
9. Clark G.T., Haynes J.J., Bayliss M.A.J., Burrows L. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice. Bioanalysis 2010, 2:1477-1488.
10. Barfields M., Spooner N., Lad R., Parry S., Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. J. Chromatogr. B 2008, 870:32-37.
11. Spooner N., Lad R., Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 2009, 81:1557-1563.
12. Mauriala T., Chauret N., Oballa R., Nicoll-Griffith D.A., Bateman K.P. A strategy for identification of drug metabolites from dried blood spots using triple-quadrupole/linear ion trap hybrid mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:1984-1992.
13. Wang L., Zeng Z., Emmons G. Exploring the feasibility of using the DBS technique for metabolite radioprofiling. Bioanalysis 2010, 2:1365-1371.
14. Tokarski J.S., Newitt J.A., Chang C.Y.J., et al. The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants. Cancer Res. 2006, 66:5790-5797.
15. Talpaz M., Shah N.P., Kantarjian H., et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 2006, 354:2531-2541.
16. 14C]Dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys. Drug Metab. Dispos. 2008, 36:1341-1356.
17. Clark G.T., Giddens G., Burrow L., Strand C. Utilization of dried blood spots within drug discovery: modification of a standard DiLab AccuSampler to facilitate automatic dried blood spot sampling. Lab. Anim. 2011, 45:124-126.
18. Uyeda C., Pham S., Fide R., Henne K., Xu G., Soto M., James C., Wong P. Application of automated dried blood spot sampling and LC-MS/MS for pharmacokinetic studies of AMG 517 in rats. Bioanalysis 2011, 3:2349-2356.
19. Paterson D., Vekich S., Hunter R., Shen Z., Rahavendran S.V. Automated pharmacokinetic sampling in the rat by both dried blood spot and liquid blood methods. AAALAS Meeting 2011.
20. Kamath A.V., Wang J., Lee F.Y., Marathe P.H. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL. Cancer Chemother. Pharmacol. 2008, 61:365-376.